Respiratory Syncytial Virus Pneumonitis in Immunocompromised Adults: Clinical Features and Outcome
Authors:
- Andrew H. LimperALAndrew H. Limper
- 1 June 2005
- journal article
- Published by S. Karger AG in Respiration
- Vol. 72 (3) , 263-269
Abstract
Background: Though predominantly an infection of children, respiratory syncytial virus (RSV) also infects adults, particularly those with immune compromise. Objectives: To define the clinical spectrum and impact of RSV pneumonitis on hospitalized, immunocompromised adults. Methods: Retrospective chart review. Clinical parameters including premorbid conditions, presentation, radiologic findings, treatment and outcome were examined in a consecutive patients series from an inpatient tertiary-care center.Eleven immunocompromised adults who had undergone bronchoalveolar lavage (BAL) between January 1987 and December 1996 and who had culture-verified RSV pneumonitis were evaluated. Results: This series consisted primarily of patients undergoing chemotherapy or bone marrow transplantation for lymphoma or leukemia. Two were immunosuppressed due to high-dose corticosteroids. A majority (91%) were admitted between November and May, with dyspnea and productive cough. In contrast to earlier studies, there was a paucity of upper respiratory infection symptoms (i.e. sinus congestion, sore throat) and a preponderance of lower respiratory physical exam findings (i.e. wheezing, bibasilar rales). Patients were typically hypoxemic and febrile prior to BAL. Eight demonstrated co-isolates of bacterial or fungi on BAL. The chest radiographs generally revealed diffuse patchy infiltrates, including alveolar opacities. Histology demonstrated diffuse alveolar damage, bronchiolitis with organizing pneumonia, and hyaline membrane formation. Over half required intubation, and 55% died. Although ribavirin therapy may be beneficial in some intubated patients, its overall efficacy cannot be established from this series. Conclusion: RSV is a serious cause of morbidity and mortality in immunocompromised adults. Further development and implementation of an effective vaccine and additional therapeutic interventions are needed.Keywords
This publication has 20 references indexed in Scilit:
- Summertime Respiratory Syncytial Virus InfectionSouthern Medical Journal, 1992
- An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant CenterThe Journal of Infectious Diseases, 1992
- Respiratory Syncytial Virus-Induced Acute Lung Injury in Adult Patients with Bone Marrow TransplantsMedicine, 1989
- Role of Bronchoalveolar Lavage in the Assessment of Opportunistic Pulmonary Infections: Utility and ComplicationsMayo Clinic Proceedings, 1987
- Respiratory Syncytial Viral Infection in Children with Compromised Immune FunctionNew England Journal of Medicine, 1986
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- Respiratory Syncytial Viral Infection in Infants with Congenital Heart DiseaseNew England Journal of Medicine, 1982
- Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunityThe Journal of Pediatrics, 1980
- Systemic cell‐mediated and antibody responses in infants with respiratory syncytial virus infectionsJournal of Medical Virology, 1980
- Respiratory-Syncytial-Virus Infections, Reinfections and ImmunityNew England Journal of Medicine, 1979